Nonmedical and medical ketamine use with Owen Bowden-Jones and Arun Sahai

Nonmedical and medical ketamine use with Owen Bowden-Jones and Arun Sahai

In this episode, Dr Elle Wadsworth speaks to Professor Owen Bowden-Jones from Central North-West London NHS Foundation and Mr Arun Sahai from Guy’s and St Thomas’ Hospitals NHS Trust, both in the UK. The interview covers an editorial they wrote with Professor Paul Dargan on responses to non-medical and medical ketamine use, including concerns about the increasing harms from illicit ketamine and excitement about the potential therapeutic value of ketamine.

We apologise for the sound quality at points during this episode, but we promise its worth the listen!

· Ketamine and its uses [01:15]

· Why ketamine is listed as an essential medicine by the World Health Organisation [01:59]

· The differing uses of ketamine: an essential medicine, a novel therapeutic drug, and a recreational drug [3:00]

· Ketamine’s damage to the urinary tract and the liver [04:30]

· Available treatments for the physical harms of ketamine [07:45]

· Whether substance use treatment services in the UK are fit-for-purpose when it comes to ketamine [11:06]

· Some of the reasons why is ketamine a popular drug now [15:38]

· The potential therapeutic value of ketamine for many disorders [17:29]

· The importance of communicating information to people who use ketamine [19:19]

About Arun Sahai: Mr Arun Sahai, PhD, FRCS (Urol), BSc (Hons.), is a Consultant Urological Surgeon in Functional urology (bladder dysfunction, incontinence, uro-neurology and urinary tract reconstruction) at Guy’s and St Thomas’ Hospitals NHS Trust and an Honorary Reader within King’s College London. He is the current chair of the section of functional and reconstructive urology at the British Association of Urological Surgeons (BAUS). He is the lead for undergraduate education in surgery for King's College London. His research interests include various aspects of benign bladder dysfunction and prostate cancer survivorship. He is active in both commercial and non-commercial clinical trials and has published more than 100 peer reviewed international papers and more than 15 book chapters.

About Owen Bowden-Jones: Professor Owen Bowden-Jones CBE is a Consultant in Addiction Psychiatry at the CNWL Club Drug Clinic, London and an Honorary Professor at University College London. In 2010, Owen founded the CNWL Club Drug Clinic, an innovative service offering treatment for emerging drug problems, including novel psychoactive substances and club drugs. National roles include President of the Society for the Study of Addiction, Chair of the Advisory Council on the Misuse of Drugs, Policy Fellow at the University of Cambridge, trustee at the charity Student Minds and Registrar at the Royal College of Psychiatrists. Owen is the past-Chair of the Faculty of Addictions at the Royal College of Psychiatrists and was previously a national clinical adviser to Public Health England.

Original editorial: Responding to medicinal and non-medicinal ketamine use https://doi.org/10.1111/add.70075

The opinions expressed in this podcast reflect the views of the host and interviewees and do not necessarily represent the opinions or official positions of the SSA or Addiction journal. The SSA does not endorse or guarantee the accuracy of the information in external sources or links and accepts no responsibility or liability for any consequences arising from the use of such information.

Hosted on Acast. See acast.com/privacy for more information.

Jaksot(102)

Pre-registration with John Marsden

Pre-registration with John Marsden

In this episode of Addiction Audio, Professor John Marsden talks about the role of pre-registration in increasing research transparency. He addresses the anxieties that people can have about pre-registration and talks about how it’s really not that difficult or daunting.Professor Marsden talks gets into the detail of pre-registration; when to register, how to register and the importance of planning for – and dealing with – missing data. He covers how plans change during any research project and how to respond when they do. The importance of pre-registration also includes qualitative research and Professor Marsden talks about the need for more qualitative and observational studies to be pre-registered.“We’re really trying to encourage people to just plan, adapt if you need to, change if you have to – but just have a clear narrative about that – and everyone benefits. It means that what was done is much more reproducible.”Professor John Marsden is the Editor-in-Chief of the journal Addiction. He is Professor of Addiction psychology at the Addictions Department, the Institute of Psychiatry, Psychology and Neuroscience, Kings College London.Marsden, J, Cousijn, J and Stapleton, J, Pre‐registration: not a daunting practice. Addiction. 2022. https://doi.org/10.1111/add.15819 Hosted on Acast. See acast.com/privacy for more information.

16 Maalis 202229min

ADHD and maternal substance use with Elis Haan

ADHD and maternal substance use with Elis Haan

Dr Elis Haan talks to Dr Rob Calder about ADHD and maternal substance use. She discusses her recent paper which explored the impact of smoking, alcohol and drugs during pregnancy on ADHD outcomes in young people.Elis talks about the differences between maternal and teacher ratings of ADHD. She also explains negative control and polygenic risk score methods used in this study discussing how multiple methods were used across different longitudinal datasets to add confidence to their analysis. “Combining these different methods can help to gain stronger support for a causal effect…. For example, if these different methods and analyses across these cohorts provide similar results we can be more confident that the results reflect a true causal effect. This is because it is unlikely that these different methods will be all biased in the same way”Haan E, Sallis HM, Zuccolo L,Labrecque J, Ystrom E, Reichborn-Kjennerud T, et al. Prenatal smoking, alcohol and caffeine exposure and maternal-reported attention deficit hyperactivity disorder symptoms in childhood: triangulation of evidence using negative control and polygenic risk score analyses. Addiction. 2021;1–14. https://doi.org/10.1111/add.15746. Hosted on Acast. See acast.com/privacy for more information.

28 Helmi 202217min

JITAIs and using smartphones to prevent lapse with Olga Perskie

JITAIs and using smartphones to prevent lapse with Olga Perskie

Rob Calder talks to Dr Olga Perski about her recent research on just-in-time adaptive interventions (JITAIs) whereby smartphones are used to help prevent lapses among people who are trying to quit or reduce alcohol, tobacco or other drug use. Dr Perski talks about why the literature is so complex and how defining JITAIs is difficult in the first place. She talks about the potential for Ecological Momentary Assessment (EMA), GPS positioning and micro-randomised trial studies to contribute in this area, and how we may not want to press ahead with full-scale RCTs before having conducted additional conceptual and computational work to clarify what JITAIs are and how to develop them. Dr Perski also discusses the challenges of regulating mobile health apps so that people can access apps based on evidence of effectiveness. This episode was recorded online on 30 September 2021.Perski, O., Hébert, E.T., Naughton, F., Hekler, E.B., Brown, J. and Businelle, M.S. Technology‐mediated just‐in‐time adaptive interventions (JITAIs) to reduce harmful substance use: A systematic review. Addiction 2021; doi:10.1111/add.15687 Hosted on Acast. See acast.com/privacy for more information.

27 Loka 202130min

Mental imagery and cocaine craving with John Marsden

Mental imagery and cocaine craving with John Marsden

Rob Calder talks to Professor John Marsden about cocaine cravings. Professor Marsden discusses the lack of pharmacological treatments for cocaine, and about his recent study using mental imagery to address cocaine cravings. He talks about the benefits of positive imagery compared with negative imagery. He then discusses how useful mixed-methods research can be and the importance of writing up data from unfinished trials. Lowry, N., Marsden, J., Clydesdale, B., Eastwood, B., Havelka, E.M. and Goetz, C. Acute impact of self‐guided mental imagery on craving in cocaine use disorder: a mixed‐methods analysis of a randomized controlled trial. Addiction 2021; doi:10.1111/add.15405https://onlinelibrary.wiley.com/doi/full/10.1111/add.15405 Hosted on Acast. See acast.com/privacy for more information.

20 Loka 202131min

Drug treatment commissioning and market mechanisms with Alison Ritter

Drug treatment commissioning and market mechanisms with Alison Ritter

Professor Alison Ritter talks about her recent paper “Are market mechanisms associated with alcohol and other drug treatment outcomes” and about the Australian context of drug treatment provision and commissioning. We discuss the challenges of measuring outcomes against commissioning structures and Professor Ritter explains how funding arrangements can end up looking like a bowl of spaghetti. Alison discusses why governments don’t necessarily have to tender competitively, about the burdens associated with the machinery of recommissioning and about the potential for fixed-price tendering to improve the quality of addiction treatment services.Ritter, A., van de Ven, K., Vuong, T., Chalmers, J., Dobbins, T., Livingston, M. and Berends, L. Are market mechanisms associated with alcohol and other drug treatment outcomes?. Addiction 2021; doi:10.1111/add.15681 https://onlinelibrary.wiley.com/doi/10.1111/add.15681 Hosted on Acast. See acast.com/privacy for more information.

15 Loka 202122min

The Paper Authoring Tool (PAT) with Robert West

The Paper Authoring Tool (PAT) with Robert West

Rob Calder talks to Professor Robert West about the Paper Authoring Tool (PAT). Professor West talks about how PAT can be used in the design and write-up phases of a randomised controlled trials, about how it saves time for reviewers and journals and about how using the PAT can make your research more rigorous, well reported and discoverable. He also discusses the future of research publishing and how computer reading can save months or years on evidence synthesis and how this relates to the Human Behaviour Change Project. There is also a small section on the interaction between computers, humans and chess.West, R. PAT: an on‐line paper authoring tool for writing up randomized controlled trials. Addiction 2021; 116: 1938-1940paperauthoringtool.com Hosted on Acast. See acast.com/privacy for more information.

14 Syys 202127min

Cannabis, opioids and the gateway hypothesis with Jack Wilson

Cannabis, opioids and the gateway hypothesis with Jack Wilson

Jack Wilson talks to Rob Calder about his recent systematic review and meta-analysis on whether cannabis use increases the likelihood of later life opioid use or opioid use disorders. Jack talks about the limitations of the literature, the influence that the gateway hypothesis has had on policy and on some of the different types of studies that explore this issue. Wilson J, Mills K, Freeman TP, Sunderland M, Visontay R, and Marel C. Weeding out the truth: a systematic review and meta-analysis on the transition from cannabis use to opioid use and opioid use disorders, abuse or dependence. Addiction 2021; doi:10.1111/add.15581 https://onlinelibrary.wiley.com/doi/abs/10.1111/add.15581 Hosted on Acast. See acast.com/privacy for more information.

15 Heinä 202116min

Cannabis, schizophrenia and genetics with Emma Johnson

Cannabis, schizophrenia and genetics with Emma Johnson

Dr Emma Johnson talks to Rob Calder about shared genetic liabilities for cannabis use disorder and schizophrenia and the role of tobacco smoking. Dr Johnson talks about the implications of this research on the evidence for a causal relationship between cannabis and schizophrenia and for other genetic associations relating to substance use and psychiatric disorders. The episode also covers to ever-fascinating issue of mendelian randomisation. (Be sure to check out episode 22 too!)Johnson E.C., Hatoum A.S., Deak J.D., Polimanti R, Murray R.M., Edenberg H.J., et al. The relationship between cannabis and schizophrenia: a genetically informed perspective. Addiction 2021 https://doi.org/10.1111/add.15534 Hosted on Acast. See acast.com/privacy for more information.

14 Kesä 202116min

Suosittua kategoriassa Tiede

rss-mita-tulisi-tietaa
utelias-mieli
tiedekulma-podcast
rss-poliisin-mieli
rss-duodecim-lehti
docemilia
mielipaivakirja
hippokrateen-vastaanotolla
filocast-filosofian-perusteet
rss-traumainformoitu-toivo
radio-antro
rss-ranskaa-raakana
rss-tiedetta-vai-tarinaa
rss-mental-race
rss-demokratian-paikat
rss-maailmanparannus-podcast
rss-ylistys-elaimille
rss-luontopodi-samuel-glassar-tutkii-luonnon-ihmeita